1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Recurrence rates among the NI-RADS categories

NI-RADS CategoriesTotalRecurrence Rate (No.)
Primary site
    NI-RADS 12543.5% (9)
    NI-RADS 23818.4% (7)
    NI-RADS 32254.6% (12)
    All primary site categories3148.9% (28)
Lymph nodes
    NI-RADS 12744.0% (11)
    NI-RADS 22015.0% (3)
    NI-RADS 31070.0% (7)
    All nodal categories3046.9% (21)
Combined primary and nodes
    NI-RADS 15283.8% (20)
    NI-RADS 25817.2% (10)
    NI-RADS 33259.4% (19)
    Combined, all categories6187.9% (49)